Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pulmonology

What Is an Acute Exacerbation of NSIP? Emergency Signs

At a Glance

An acute exacerbation of NSIP is a sudden, serious worsening of breathing with new changes on a lung CT scan over existing inflammation or scarring. It requires urgent hospital evaluation to rule out infection, heart failure, blood clots, and other emergencies.

A sudden worsening of breathing is a medical emergency. Call 911 or your local emergency number immediately if you experience:

  • Severe or rapidly worsening breathlessness over days or weeks
  • Inability to speak in full sentences
  • Blue or gray lips or fingertips
  • Confusion, dizziness, or fainting
  • Severe chest pain
  • A rapid drop in your oxygen levels compared to your individualized baseline plan

Do not delay emergency care to try and contact your pulmonology office first. If possible, bring your current medication list (especially exact doses of immunosuppressants) and a record of your baseline oxygen needs, but do not wait if you are unstable.

What is an Acute Exacerbation?

An acute exacerbation of non-specific interstitial pneumonia (NSIP) is a sudden, clinically significant worsening of your breathing, typically developing in less than a month (often over days or weeks) [1][2].

On a CT scan, it is identified by new, hazy areas (called ground-glass opacities) or denser patches where air in the lung is replaced by fluid or tissue (called consolidation) layered over your existing lung scarring or inflammation [3][2].

However, because your lungs are already compromised by NSIP, they are highly vulnerable to other life-threatening issues. A diagnosis of an acute exacerbation involves confirming this sudden worsening and new CT imaging, while also ensuring the changes are not fully explained by heart failure or fluid overload [3].

Why Doctors Look for Triggers and Alternatives

If you suddenly cannot breathe, your medical team will urgently investigate other emergencies that can trigger a flare-up or mimic one perfectly:

  • Infections: Bacterial pneumonia, respiratory viruses, and opportunistic infections (like Pneumocystis jirovecii pneumonia [PJP], an infection affecting people with weakened immune systems) can cause new, hazy spots on a scan [4][5]. Infections are a frequent trigger of true exacerbations [6].
  • Heart Problems: Heart failure or pulmonary edema (fluid backing up into the lungs) can severely limit breathing and create imaging results that look like an exacerbation [3][7].
  • Blood Clots: A pulmonary embolism (a blood clot in the lung) restricts oxygen levels. It requires specialized imaging to diagnose and is treated with individualized blood thinners or other therapies, depending on your risk factors and stability [6].
  • Other Complications: Doctors may also evaluate for a pneumothorax (a collapsed lung) and drug-induced pneumonitis (lung injury caused by medications used to treat NSIP or other conditions) [8].

Emergency Testing in the Hospital

When you arrive at the hospital, the immediate priority is stabilizing your airway, breathing, and oxygen levels. Once you are stable, testing typically involves:

  • CT Scans: A CT scan is used to check for new lung damage, fluid, or infection [9]. If doctors suspect a blood clot, they will use a specific type of scan called a CT pulmonary angiogram [2].
  • Heart Evaluations: You may receive an ECG (electrocardiogram), an echocardiogram (ultrasound of the heart), and blood tests to assess heart strain or fluid overload [10].
  • Microbiology Tests: Your care team will run blood cultures, sputum tests, and respiratory viral swabs to check for infections [11].
  • Bronchoscopy: In some instances, a pulmonologist may perform a bronchoalveolar lavage (BAL). This involves washing a small part of the lung with sterile fluid to collect cells and test for hard-to-find infections, though it is not strictly required to diagnose an exacerbation [12].

Hospital Treatment and Management

Treatment focuses on aggressively supporting your breathing and addressing any underlying triggers. There is no single universally proven treatment regimen [13].

  • Oxygen and Ventilation: You will likely need supplemental oxygen, often delivered through a High-Flow Nasal Cannula (HFNC) or a non-invasive breathing mask (like a CPAP or BiPAP machine) [14][15]. Invasive mechanical ventilation (a breathing machine with a tube in your airway) is considered high-risk for patients with scarred lungs but can be lifesaving for reversible triggers or as a bridge to a lung transplant; decisions are highly individualized [16].
  • Medications: Because an infection can be hard to rule out immediately, doctors may start you on empiric broad-spectrum antibiotics while awaiting test results, narrowing or stopping them if no infection is found [2]. If an exacerbation is suspected, the specialist team may consider high doses of intravenous corticosteroids to reduce inflammation, though evidence for their benefit is limited and treatment must be weighed against the risk of worsening an infection [13][2].
  • Palliative Care: Palliative care specialists are often involved alongside your intensive active treatment. They do not mean you are at the end of life or that treatment has stopped; they are experts in aggressively managing severe symptoms like breathlessness and anxiety, and they help you and your family communicate your goals with the medical team [17].
  • Transplant Care: Depending on the severity and trajectory of your disease, your overall health, and transplant eligibility, your team may consult a lung transplant center to assess your options before further deterioration [18].

A Critical Warning: Never Self-Treat a Flare-Up

If your breathing suddenly worsens, do not self-start high-dose steroids or increase your immunosuppressant medications at home. Because an exacerbation looks and feels identical to a severe bacterial or viral infection, taking high doses of steroids without a doctor’s supervision could dangerously suppress your immune system right when it needs to fight an illness. This can lead to life-threatening complications, including severe fungal infections [18][19]. Always treat sudden respiratory worsening as an emergency.

Prognosis and Recovery

An acute exacerbation is a serious event requiring intensive, specialized care. Outcomes vary substantially depending on whether your NSIP is primarily cellular (more inflammatory) or fibrotic (more scarred), what triggered the event, and your baseline lung function [20][21].

While available data is limited, research suggests that patients with non-IPF conditions (such as NSIP) may have a somewhat better chance of recovery than those with Idiopathic Pulmonary Fibrosis (IPF) [22][23]. Recovery takes time. Even if you did not use oxygen before, you may need supplemental oxygen therapy after leaving the hospital, which your pulmonologist will periodically reassess [22].

Common questions in this guide

What does an acute exacerbation of NSIP mean?
It means breathing has worsened suddenly and significantly, usually over days to weeks and within about one month, in someone with NSIP. A CT scan shows new hazy or dense lung changes on top of existing inflammation or scarring, after doctors assess other causes such as heart failure or fluid overload.
When should I call 911 for an NSIP flare?
Call 911 or local emergency services for severe or rapidly worsening breathlessness, inability to speak in full sentences, blue or gray lips or fingertips, confusion, fainting, severe chest pain, or a rapid oxygen drop below your individualized plan. Do not wait to contact the pulmonology office first if you are unstable.
How do doctors tell an NSIP exacerbation from an infection or heart problem?
Doctors use a CT scan and may perform a special CT scan for blood clots, along with heart tests, blood tests, cultures, sputum testing, and viral swabs. These tests look for infection, fluid from heart failure, blood clots, a collapsed lung, or medication-related lung injury that can mimic or trigger an exacerbation.
How is an acute NSIP exacerbation treated in the hospital?
Treatment may include supplemental oxygen, high-flow oxygen through the nose, or a noninvasive breathing mask; a ventilator is considered in selected severe cases. Doctors may start broad-spectrum antibiotics while infection is being evaluated and may consider intravenous corticosteroids when an exacerbation is suspected, but there is no single proven regimen and decisions are individualized.
Should I increase my steroids or immunosuppressants at home?
No. Do not start high-dose steroids or increase immunosuppressants without medical supervision because a serious infection can look like an exacerbation, and extra immune suppression can worsen infections, including fungal infections. Sudden breathing worsening should be treated as an emergency.
Can people recover from an acute exacerbation of NSIP?
Recovery varies with whether the NSIP is more inflammatory or scarred, the trigger, and baseline lung function. Some people need oxygen after leaving the hospital, and their pulmonologist should reassess it; the outlook may be better for NSIP than for idiopathic pulmonary fibrosis, but every case is different.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Non-specific interstitial pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I go to the emergency room with sudden shortness of breath, what specific words should I use to ensure they understand my NSIP and the risk of an exacerbation?
  2. 2.What are my baseline oxygen requirements and lung function numbers, so I can share them with emergency staff for comparison?
  3. 3.What is my individualized plan for monitoring my oxygen levels at home, and what specific drop in oxygen saturation means I need to call 911?
  4. 4.Are there any prophylactic (preventative) medications I should be taking to prevent infections while on my current immunosuppressants?
  5. 5.How and when will we reassess my need for supplemental oxygen after I recover and leave the hospital?

References

References (23)
  1. 1

    Acute exacerbations of progressive-fibrosing interstitial lung diseases.

    Kolb M, Bondue B, Pesci A, et al.

    European respiratory review : an official journal of the European Respiratory Society 2018; (27(150)) doi:10.1183/16000617.0071-2018.

    PMID: 30578331
  2. 2

    Acute Exacerbation of Interstitial Lung Disease: Early Diagnosis and Treatment.

    León-Román F, Martínez-Besteiro E, Iturbe D, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(12)) doi:10.3390/medicina61122097.

    PMID: 41470099
  3. 3

    Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.

    Kondoh Y, Cottin V, Brown KK

    European respiratory review : an official journal of the European Respiratory Society 2017; (26(145)) doi:10.1183/16000617.0050-2017.

    PMID: 28954766
  4. 4

    Lung Diseases in Inflammatory Myopathies.

    Barba T, Mainbourg S, Nasser M, et al.

    Seminars in respiratory and critical care medicine 2019; (40(2)):255-270 doi:10.1055/s-0039-1685187.

    PMID: 31137064
  5. 5

    Pneumocystis Pneumonia Presenting With Peripheral Predominant Consolidation and Traction Bronchiectasis.

    Fujishima N, Hioki Y, Yokoyama A, et al.

    Cureus 2024; (16(6)):e63257 doi:10.7759/cureus.63257.

    PMID: 39070459
  6. 6

    Acute Exacerbation in Interstitial Lung Disease.

    Leuschner G, Behr J

    Frontiers in medicine 2017; (4()):176 doi:10.3389/fmed.2017.00176.

    PMID: 29109947
  7. 7

    The Significance of Subpleural Sparing in CT Chest: A State-of-the-Art Review.

    Chong WH, Saha BK, Austin A, Chopra A

    The American journal of the medical sciences 2021; (361(4)):427-435 doi:10.1016/j.amjms.2021.01.008.

    PMID: 33487401
  8. 8

    Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society.

    Johkoh T, Lee KS, Nishino M, et al.

    Chest 2021; (159(3)):1107-1125 doi:10.1016/j.chest.2020.11.027.

    PMID: 33450293
  9. 9

    Imaging Review of the Lung Parenchymal Complications in Patients with IPF.

    Baratella E, Fiorese I, Marrocchio C, et al.

    Medicina (Kaunas, Lithuania) 2019; (55(10)) doi:10.3390/medicina55100613.

    PMID: 31547107
  10. 10

    Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.

    Nagasawa R, Hara Y, Murohashi K, et al.

    BMC pulmonary medicine 2020; (20(1)):310 doi:10.1186/s12890-020-01341-1.

    PMID: 33238962
  11. 11

    Infectious respiratory pathogens among patients with acute exacerbation of idiopathic pulmonary fibrosis during the coronavirus disease 2019 pandemic in Japan.

    Akata K, Yamasaki K, Kawaguchi T, et al.

    Heart & lung : the journal of critical care 2024; (67()):1-4 doi:10.1016/j.hrtlng.2024.03.007.

    PMID: 38569435
  12. 12

    Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.

    Kono M, Miyashita K, Hirama R, et al.

    Respiratory medicine 2021; (186()):106534 doi:10.1016/j.rmed.2021.106534.

    PMID: 34260978
  13. 13

    Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review.

    Srivali N, De Giacomi F, Moua T, Ryu JH

    Thorax 2025; (80(3)):140-149 doi:10.1136/thorax-2024-222636.

    PMID: 39721758
  14. 14

    Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.

    Koyauchi T, Yasui H, Enomoto N, et al.

    Therapeutic advances in respiratory disease 2020; (14()):1753466620906327 doi:10.1177/1753466620906327.

    PMID: 32046604
  15. 15

    Impact of oxygenation strategies on outcome in acute exacerbation of interstitial lung disease.

    Thévenin R, Gillibert A, Dognon N, et al.

    ERJ open research 2025; (11(6)) doi:10.1183/23120541.00053-2025.

    PMID: 41257178
  16. 16

    Mechanical Ventilation and Predictors of In-Hospital Mortality in Fibrotic Interstitial Lung Disease With Acute Respiratory Failure: A Cohort Analysis Through the Paradigm of Acute Respiratory Distress Syndrome.

    Martin MJ, Moua T

    Critical care medicine 2020; (48(7)):993-1000 doi:10.1097/CCM.0000000000004366.

    PMID: 32355133
  17. 17

    Acute exacerbation of interstitial lung disease in the intensive care unit: Principles of diagnostic evaluation and management.

    Hayat Syed MK, Bruck O, Kumar A, Surani S

    World journal of critical care medicine 2023; (12(3)):153-164 doi:10.5492/wjccm.v12.i3.153.

    PMID: 37397591
  18. 18

    Interstitial Lung Disease: A Focused Review for the Emergency Clinician.

    Constantino K, Gottlieb M, Long B

    The Journal of emergency medicine 2023; (64(2)):156-166 doi:10.1016/j.jemermed.2022.10.015.

    PMID: 36707347
  19. 19

    A case of invasive pulmonary aspergillosis during treatment for acute exacerbation of interstitial lung disease.

    Ugajin M, Kani H

    Infectious disease reports 2018; (10(3)):7785 doi:10.4081/idr.2018.7785.

    PMID: 30662692
  20. 20

    Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.

    Faverio P, Stainer A, Conti S, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(9)) doi:10.3390/diagnostics11091623.

    PMID: 34573965
  21. 21

    Prognostic comparison of acute exacerbations across idiopathic interstitial pneumonia subtypes: A nationwide observational study.

    Awano N, Aso S, Izumo T, et al.

    Respiratory investigation 2025; (63(6)):1229-1234 doi:10.1016/j.resinv.2025.10.001.

    PMID: 41056590
  22. 22

    Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.

    Miyashita K, Kono M, Saito G, et al.

    The clinical respiratory journal 2021; (15(3)):336-344 doi:10.1111/crj.13304.

    PMID: 33197284
  23. 23

    Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.

    Salonen J, Purokivi M, Bloigu R, Kaarteenaho R

    BMJ open respiratory research 2020; (7(1)) doi:10.1136/bmjresp-2020-000563.

    PMID: 32265195

This page is for informational purposes only and does not constitute medical advice. Sudden or rapidly worsening breathing requires emergency care; your emergency team and pulmonologist should guide decisions about testing and treatment.